Vivo Capital raises $532 mln for fund

Vivo Capital, a healthcare investment firm, has closed its opportunity fund at $532 million. Vivo Opportunity Fund will focus on small to mid-cap public life sciences companies.

12 September 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail